Cutter Capital Management, LP
Follow13F filer, CIK 1983313, NEW YORK, NY
Cutter Capital Management, LP reported $0 across 1 holding for the quarter ended 2025-06-30, in a 13F-HR filed 2025-07-24.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-25-010866
- Period
- 2025-06-30
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- 1
- Sold out
- 21
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BMYexited | -295,000 | -$18M |
| AMGNexited | -50,000 | -$15.6M |
| BIIBexited | -113,500 | -$15.5M |
| LLYexited | -18,000 | -$14.9M |
| INSMexited | -186,384 | -$14.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2025
Share positions as resolved from 13F-HR 0001214659-25-010866, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | new | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
Sold out in Q2 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| BMYBRISTOL-MYERS SQUIBB CO | 295,000 | $18M | shares |
| AMGNAMGEN INC | 50,000 | $15.6M | shares |
| BIIBBIOGEN INC | 113,500 | $15.5M | shares |
| LLYELI LILLY & CO | 18,000 | $14.9M | shares |
| INSMINSMED INC | 186,384 | $14.2M | shares |
| RAREULTRAGENYX PHARMACEUTICAL IN | 379,303 | $13.7M | shares |
| BBIOBRIDGEBIO PHARMA INC | 390,644 | $13.5M | shares |
| PRGOPERRIGO CO PLC | 479,517 | $13.4M | shares |
| ROIVROIVANT SCIENCES LTD | 1,300,000 | $13.1M | shares |
| TEVATEVA PHARMACEUTICAL INDS LTD | 801,806 | $12.3M | shares |
| RPRXROYALTY PHARMA PLC | 356,894 | $11.1M | shares |
| TARSTARSUS PHARMACEUTICALS INC | 205,000 | $10.5M | shares |
| VERONA PHARMA PLCVERONA PHARMA PLC | 160,000 | $10.2M | shares |
| MDGLMADRIGAL PHARMACEUTICALS INC | 24,000 | $7.95M | shares |
| SMMTSUMMIT THERAPEUTICS INC | 400,000 | $7.72M | shares |
| HALOHALOZYME THERAPEUTICS INC | 120,000 | $7.66M | shares |
| CYTKCYTOKINETICS INC | 175,000 | $7.03M | shares |
| AGIOAGIOS PHARMACEUTICALS INC | 235,350 | $6.9M | shares |
| CNTACENTESSA PHARMACEUTICALS PLC | 418,127 | $6.01M | shares |
| RCUSARCUS BIOSCIENCES INC | 731,818 | $5.74M | shares |
| NAMSNEWAMSTERDAM PHARMA COMPANY | 221,152 | $4.53M | shares |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001214659-25-010866 | base | 2025-07-24 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-25-010866 | Quarter ended 2025-06-30 | 2025-07-24 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-25-007818 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-25-002829 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-019126 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-014671 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001214659-24-013872 | Quarter ended 2024-03-31 | 2024-08-06 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-009296 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001214659-24-002814 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set |